CLOV Clover Health Investments, Corp.
CLOV Clover Health Investments, Corp.
Healthcare · Healthcare Plans
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $2.50 · VWAP $3.33 · +34.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, VP + 2 others sold $1.6M, Sep 14–18
CLOV Price Structure
Loading timeframes…
Decision history
2 scored calls · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-30: revenue $743M, diluted EPS $0.05, net income $28M (SEC filing). Across the print the stock moved +9.1% (close before → first close after).
full note →Against street estimates
How CLOV's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
CLOV research tape
73 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.